S6tero del Rio, Santiago. Chile.
Zinc deficiency may affect pregnancy outcome. In order to begin study of zinc status in Chilean population of low income groups. we studied 124 pregnant teenagers on admission to their prenatal controls. They were 16.3 + 1.4 years old (12) (13) (14) (15) (16) (17) (18) . beginning pregnancy controls at 12.6 +_ 3.7 weeks (7-20); nutritional status showed 28"seficit of weigth for height and gestational age. Dictary history records revealed daily intakes of: Zn 6.8 2 2.7 mg. or 0.81 mg/MJ (42.5% of reccomendations); iron 18.3 2 7.6 mg or 8.9 mg/1088 Kcal (60% of RDA) with 4 7 . 5 W animal origin; vegetal fiber 5.3 + 2.8 g. Plasma zinc was 96.3 +_ 13.7 ug/dl (15/126<80 ug/dl; Hb 13.0 + 1.3) (4/116<11 g/d).
We conclude that Chilean pregnant teenagers of low income groups present a higher prevalence of low zinc intakes than of other nutrients. these low intakes are not associated to low plasma zinc.
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INSULIN LIKE GROWTH FACTOR-I IN SEXUAL PRECOCITY. MDS. Carvalho.
RJ. Teixeira; JR. Freitas; AA. Guimaraes; HF. Souza; MM. Guimaraes.
Endocrine Service -University Hospital CFF-Fedetal University Rio de Janeiro -Rio de Janeiro. Brazil.
We evaluated the plasma levels of IGF-I in 33 girls with sexual precocity to assess its efficacy as a discriminating diagnostic tool berween precocious puberty and variants of pubertal development (pubarche and thelarche). The assays were performed using an extraction process. IGF-I levels were elvated in 5 cases of precocious puberty. They averaged 0.87 + 0.38 U/ml in precocious puberty. 0.63 5 0.21 U/ml in pubarche and 0.47 +_ 0.14 U/ml in thelarche. There was a significant difference (p < 0.05) between levels of IGF-I in precocious puberty and thelarche by the Bonferroni test. We conclude that the isolated determination of IGF-I is not a discrimating diagnostic test between the forms of sexual precocity. Elevated levels can be useful. suggesting the diagnosis of precocious puberty. Thyroid ecography was performed in 29 patients with CH and. thyroid scanning with tecnecium was performed in 26. Twenty two cases of thyroid dysgenesis were identified by scanning. 14 had athyreosis. 2 had hypoplasia and 6 had an ectopic gland. In all 22 cases, a concomitant ecographic study showed an absent gland in the cervical region. In the other 3 patients, which were not scanned. ecographic studies identified a detectable gland, which was compatible with the diagnosis of thyroid dysgenesis. In 3 patients. the ecography identified gland at the usual site. which concentrated isotope in two cases, and did not concentrated in the third. compatible with abnormal synthesis or secretion. In one, there was a large goiter, clinically palpable at birth. Another case was of recurrent CH in the same family. characterized by autosomic inheritance suggesting dishormonogenesis. The third case appeared to represent a possible TSH receptor defect or a trapping abnormality. In one case, the gland was identified by both diagnostic procedures. It was our only case of transitory CH. In conclusion. ecography is a very sensitive method for the diagnosis of thyroid dysgenesis. although it cannot discriminate the form. On the other hand. identifing gland in a suspicious case of CH suggests dyshormonogenesis or transitory CH. which has important clinical implications.
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EFFECT Zinc has multiple effects on somatic development: It acts as a cofactor in IGF-I actionsit is part of several enzymatic systems. releases growth hormone (GH) and influences DNA and RNA metabolism. We studied 15 prepubertal boys with short stature (height <-2SD) and peak GH levels after ITT or clonidine stimulation test > 7 ng/ml. After a pretreatment period of at least 6 months, zinc sulfate x 7H20 70 mg. Our objetive was to analyze the bone density of the lumbar spine (Ll-IA)expressed by Z index-(Xa-Xn1ISD)of BMD(gIcm2)in 17 patients. 12 females and 5 males, with hypergonatropic hypogonadism(HH) under hormonal replacement therapy. Young normal adults were taken as reference.The bone densitomet~y was performed by Hologic apparatus QDT.1BBBIw (SIN 871). The 12 females patients were 12 or 31 years old at the beginning of treatment(X+SD-19.5+6.8). Ten patients had Turner's Syndrome. one case had 46.W and one case had 46,XX gonadal dysgenesis. The patients were treated with conjugated estrogens (0.15-0.625 mg). estrogen esters (2mg) or ethinyl estradiol (30-50 ug/d) associated with progesterone for a period of one to sixteen years. The 5 male patients were 13 to 21 years old at the beginning of treatment (XgD -17.Bc2.9) Four of these patients had Klinefelter's Syndrome and one patient had anorchia. They were treated with testosterone esters at a dose of 125 to 250mg every 15 to 21 days for a period of 4 to 8 years (X+SD-5.6 +_1.6).The female Z index changed from -4.05 to -1.2 and the male Z index changed from -1.69 to + 2.7. We did not observe any relation between chronological age at the begining of treatment or the length of treatment (p4.05). All female patients showed negative Z scores and in 5 the value was below -2SD. All the males had Z scores within ZSD of normal controls. We conclude that androgen replacement therapy was able to preserve bone mass. while estrogen replacement therapy was not able to normalize bone mass. This observation suggests that complementa-should W d A n female HIL
